StockTipsArenaBeta

BUY Zydus Lifesciences Limited — Nagaraj Shetty, HDFC Securities

BUYZydus Lifesciences Limited
Zydus Lifesciences share price target & all analyst calls

byNagaraj Shetty, HDFC SecuritiesHorizon: 1–3 months28 Oct 2026via LiveMint Markets

Entry₹1,175.5Inferred
Target₹1,268
Total upside +7.87%
Stop loss₹1,123-4.47% risk
CMP₹1,181.1Just now
Active+0.48%+7.36%upside left 3 mo left
Follow Nagaraj Shetty for new calls(55% target hit, 29 closed calls)Get alertsWatch ZYDUSLIFE for new buy/sell callsGet alertsSee 1 other Short-term call on ZYDUSLIFESee 64 other Short-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 29 Oct, 11:43 am IST
12 supporting2 neutral5 opposing
Supports the BUY call (12)

MACD above its signal line — bullish momentum

Technicals · macd·29 Oct · today

8 advisors have active long-term BUY calls on this stock, with 3 issued in the last 14 days

Advisor consensus · adjacent horizon·28 Oct · today

1 other SEBI-registered advisor has an active short-term BUY call on this stock, issued in the last 14 days

Advisor consensus · same horizon·26 Oct · 2d ago

Zydus Lifesciences' subsidiary Zylidac Bio has partnered with Prolific Machines to scale a biologics manufacturing platform to GMP production.

BSE · Company Update·21 Oct · 1w ago

(opens in new tab)

Zydus Lifesciences received USFDA approval for Estradiol and Levonorgestrel Transdermal System, qualifying for 180-day competitive generic therapy exclusivity.

BSE · Company Update·21 Oct · 1w ago

(opens in new tab)
Neutral / worth noting (2)

Q2 FY27 results scheduled — board meets 04 Nov 2026

BSE · Board Meeting·In 6 days

(opens in new tab)

Zydus hits 52-week high, can the optimism continue?

NewsLivemint·29 Sept · 4w ago

(opens in new tab)
Weighs against the BUY call (5)

Zydus Lifesciences In Focus As US FDA Flags Data Integrity, Quality Control Issues At Gujarat Plant

NewsNdtv-Profit·26 Oct · 2d ago

(opens in new tab)

Zydus Lifesciences' USFDA inspection at Ahmedabad plant concludes with 5 observations

NewsCnbc-Tv18·13 Oct · 2w ago

(opens in new tab)

The USFDA concluded an inspection of Zydus Lifesciences' Moraiya manufacturing plant with 5 observations, which the company intends to address.

NSE · Press Release·13 Oct · 2w ago

(opens in new tab)

The USFDA concluded an inspection of the company's Moraiya manufacturing plant with 5 observations.

BSE · Company Update·13 Oct · 2w ago

(opens in new tab)

1 advisor has an active long-term SELL call on this stock

Advisor consensus · adjacent horizon·12 Aug · 3mo ago

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Zydus Lifesciences

All analyst calls on Zydus Lifesciences

More from Nagaraj Shetty, HDFC Securities

Every call and its outcome